Update on first-line treatment of advanced ovarian carcinoma by Kemp Z, Ledermann JA

Get full text

Combining conventional therapy with immunotherapy: A risky business? by Coosemans, A, Vankerckhoven, A, Baert, T, Boon, L, Ruts, H, Riva, M, Blagden, S, Delforge, M, Concin, N, Mirza, MR, Ledermann, JA, Du Bois, A, Vergote, I

Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, control... by Blagden, S, Cook, AD, Poole, C, Howells, L, McNeish, IA, Dean, A, Kim, JW, O’Donnell, DM, Hook, J, James, EC, White, IR, Perren, T, Lord, R, Dark, G, Earl, HM, Hall, M, Kaplan, R, Ledermann, JA, Clamp, AR